BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 37360468)

  • 1. Advances in Nanotechnology for Biofilm Inhibition.
    Kumar L; Bisen M; Harjai K; Chhibber S; Azizov S; Lalhlenmawia H; Kumar D
    ACS Omega; 2023 Jun; 8(24):21391-21409. PubMed ID: 37360468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanotechnology-based drug delivery systems for control of microbial biofilms: a review.
    Dos Santos Ramos MA; Da Silva PB; Spósito L; De Toledo LG; Bonifácio BV; Rodero CF; Dos Santos KC; Chorilli M; Bauab TM
    Int J Nanomedicine; 2018; 13():1179-1213. PubMed ID: 29520143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Nanotherapeutics as Next-generation Anti-infective Agents: Current Trends and Future Prospectives.
    Subhaswaraj P; Syed A; Siddhardha B
    Curr Drug Discov Technol; 2020; 17(4):457-468. PubMed ID: 31309893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanotechnology in combating biofilm: A smart and promising therapeutic strategy.
    Mohanta YK; Chakrabartty I; Mishra AK; Chopra H; Mahanta S; Avula SK; Patowary K; Ahmed R; Mishra B; Mohanta TK; Saravanan M; Sharma N
    Front Microbiol; 2022; 13():1028086. PubMed ID: 36938129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Nanotechnologies to Overcome the Bacterial Biofilm Matrix Barriers.
    Lv X; Wang L; Mei A; Xu Y; Ruan X; Wang W; Shao J; Yang D; Dong X
    Small; 2023 Feb; 19(6):e2206220. PubMed ID: 36470671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanotechnologies for control of pathogenic microbial biofilms.
    Asare EO; Mun EA; Marsili E; Paunov VN
    J Mater Chem B; 2022 Jul; 10(27):5129-5153. PubMed ID: 35735175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of microbial biofilms - the contribution of micro and nanostructured materials.
    Grumezescu AM; Chifiriuc CM
    Curr Med Chem; 2014; 21(29):3311. PubMed ID: 24606506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanotechnology: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(19):1-43. PubMed ID: 23074489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of
    Arunachalam K; Pandurangan P; Shi C; Lagoa R
    Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839634
    [No Abstract]   [Full Text] [Related]  

  • 10. Overcoming Multidrug Resistance of Antibiotics via Nanodelivery Systems.
    Imran M; Jha SK; Hasan N; Insaf A; Shrestha J; Shrestha J; Devkota HP; Khan S; Panth N; Warkiani ME; Dua K; Hansbro PM; Paudel KR; Mohammed Y
    Pharmaceutics; 2022 Mar; 14(3):. PubMed ID: 35335962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging strategies in nanotechnology to treat respiratory tract infections: realizing current trends for future clinical perspectives.
    Chen M; Shou Z; Jin X; Chen Y
    Drug Deliv; 2022 Dec; 29(1):2442-2458. PubMed ID: 35892224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promising advances in nanobiotic-based formulations for drug specific targeting against multidrug-resistant microbes and biofilm-associated infections.
    Elfadil D; Elkhatib WF; El-Sayyad GS
    Microb Pathog; 2022 Sep; 170():105721. PubMed ID: 35970290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoantibiotics: A Novel Rational Approach to Antibiotic Resistant Infections.
    Engin AB; Engin A
    Curr Drug Metab; 2019; 20(9):720-741. PubMed ID: 31385767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanotechnology as a Promising Approach to Combat Multidrug Resistant Bacteria: A Comprehensive Review and Future Perspectives.
    Hetta HF; Ramadan YN; Al-Harbi AI; A Ahmed E; Battah B; Abd Ellah NH; Zanetti S; Donadu MG
    Biomedicines; 2023 Jan; 11(2):. PubMed ID: 36830949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Micro/nanosystems and biomaterials for controlled delivery of antimicrobial and anti-biofilm agents.
    Bianchera A; Buttini F; Bettini R
    Expert Opin Ther Pat; 2020 Dec; 30(12):983-1000. PubMed ID: 33078643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanotechnological strategies for systemic microbial infections treatment: A review.
    Dos Santos Ramos MA; Dos Santos KC; da Silva PB; de Toledo LG; Marena GD; Rodero CF; de Camargo BAF; Fortunato GC; Bauab TM; Chorilli M
    Int J Pharm; 2020 Nov; 589():119780. PubMed ID: 32860856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Antibiofilm Nanosystems for Improved Infection Inhibition of Microbes in Skin.
    Lin YK; Yang SC; Hsu CY; Sung JT; Fang JY
    Molecules; 2021 Oct; 26(21):. PubMed ID: 34770799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposomes as Antibiotic Delivery Systems: A Promising Nanotechnological Strategy against Antimicrobial Resistance.
    Ferreira M; Ogren M; Dias JNR; Silva M; Gil S; Tavares L; Aires-da-Silva F; Gaspar MM; Aguiar SI
    Molecules; 2021 Apr; 26(7):. PubMed ID: 33918529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent progress in nanotechnology for cancer therapy.
    Tang MF; Lei L; Guo SR; Huang WL
    Chin J Cancer; 2010 Sep; 29(9):775-80. PubMed ID: 20800018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial Biofilm Inhibition: A Focused Review on Recent Therapeutic Strategies for Combating the Biofilm Mediated Infections.
    Srinivasan R; Santhakumari S; Poonguzhali P; Geetha M; Dyavaiah M; Xiangmin L
    Front Microbiol; 2021; 12():676458. PubMed ID: 34054785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.